Cargando…
Excipient lung disease in a patient taking the benzodiazepine derivative etizolam: A case report
Excipient Lung Disease is an inflammatory response to the intravenous administration of oral formulations of drugs and their excipients (additives). Previously described offenders include opioids and Ritalin, whose excipients, when crushed and administered intravenously, lead to inflammation and are...
Autores principales: | Smith, Ben C, Grant, Thomas, Allen, Bradley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818925/ https://www.ncbi.nlm.nih.gov/pubmed/35145565 http://dx.doi.org/10.1016/j.radcr.2022.01.035 |
Ejemplares similares
-
Metabolic Profile Analysis of Designer Benzodiazepine Etizolam in Zebrafish and Human Liver Microsomes
por: Jie, Zhaowei, et al.
Publicado: (2023) -
A case of etizolam dependence
por: Gupta, Sumit, et al.
Publicado: (2014) -
The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine
por: Kolbe, V., et al.
Publicado: (2020) -
A successful case of dose reduction in etizolam dependence using fine granules: a case report
por: Nishii, Shigeki, et al.
Publicado: (2014) -
Treatment of concurrent etizolam and tianeptine withdrawal following accidental overdose
por: Markovic, Marija, et al.
Publicado: (2023)